Nyrada Inc. (ASX:NYR)
Australia · Delayed Price · Currency is AUD 0.4700
+0.0450 (10.59%)
Oct 21, 2026, 4:10 PM AEDT
Nyrada Market Cap
Nyrada has a market cap or net worth of 116.37 million as of October 21, 2026. It is the 27,214th most valuable company in the world and the 596th biggest in Australia. Its market cap has increased by 29.84% in one year.
Market Cap
116.37M
Enterprise Value
107.98M
Revenue
2.01M
Global Rank
Country Rank
#596 Australia
PE Ratio
n/a
ChartMarket Cap Chart
Since January 16, 2020, Nyrada's market cap has increased from 25.71M to 116.37M, an increase of 352.71%. That is a compound annual growth rate of 25.00%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 21, 2026 | 116.37M | -57.29% |
| Dec 31, 2025 | 272.45M | 1,278.00% |
| Dec 31, 2024 | 19.77M | 476.06% |
| Dec 29, 2023 | 3.43M | -84.83% |
| Dec 30, 2022 | 22.62M | -39.58% |
| Dec 31, 2021 | 37.44M | 42.63% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Orthocell | 177.06M |
| Actinogen Medical | 177.00M |
| Paradigm Biopharmaceuticals | 146.80M |
| Dimerix | 126.08M |
| Island Pharmaceuticals | 99.19M |
| Recce Pharmaceuticals | 88.67M |
| LTR Pharma | 86.58M |
| Alterity Therapeutics | 73.31M |